+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan Plc
  • Horizon Pharma Plc
  • Jazz Pharmaceuticals Plc
  • Mallinckrodt Plc
  • Purdue Pharma LP
  • MORE
Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Critical Information Included:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies. It sells generic products principally in the US in various categories including urology, pain management, central nervous system (CNS) disorders, immunosuppression, cancer, cardiovascular diseases and women’s health among others. The company offers branded pharmaceuticals for conditions related to urology, orthopedics, endocrinology and pain management. Endo also provides over-the-counter (OTC) products, which include dermatological products and anti-infectives. The company sells its products through independent wholesale distributors, to retailers, government agencies, doctors, clinics, independent retail and specialty pharmacies and independent specialty distributors. Endo is headquartered in Dublin, Ireland.

Endo International Plc Key Recent Developments

Mar 23, 2019 Sojournix Poster Presentation At ENDO 2019 Features Positive Data From SJX-653 Proof-of-Mechanism Clinical Study
Mar 04, 2019 Right on Brands (RTON) Exclusive Distribution Deal With South Florida Budweiser Distributor For ENDO Brands Products Kicks off sales week
Mar 01, 2019 Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting
Feb 28, 2019 Endo reports fourth-quarter and full year 2018 financial results

Key Benefits Include

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan Plc
  • Horizon Pharma Plc
  • Jazz Pharmaceuticals Plc
  • Mallinckrodt Plc
  • Purdue Pharma LP
  • MORE
Section 1 - About the Company
  • Endo International Plc - Key Facts
  • Endo International Plc - Key Employees
  • Endo International Plc - Key Employee Biographies
  • Endo International Plc - Major Products and Services
  • Endo International Plc - History
  • Endo International Plc - Company Statement
  • Endo International Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Endo International Plc - Business Description
  • Business Segment: International Pharmaceuticals
  • Overview
  • Performance
  • Business Segment: U.S. Branded - Specialty & Established Pharmaceuticals
  • Overview
  • Performance
  • Business Segment: U.S. Branded - Sterile Injectables
  • Overview
  • Performance
  • Business Segment: U.S. Generic Pharmaceuticals
  • Overview
  • Performance
  • R&D Overview
  • Endo International Plc - Corporate Strategy
  • Endo International Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Endo International Plc - Strengths
  • Endo International Plc - Weaknesses
  • Endo International Plc - Opportunities
  • Endo International Plc - Threats
  • Endo International Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Endo International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Endo International Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Endo International Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 23, 2019: Sojournix Poster Presentation At ENDO 2019 Features Positive Data From SJX-653 Proof-of-Mechanism Clinical Study
  • Mar 04, 2019: Right on Brands (RTON) Exclusive Distribution Deal With South Florida Budweiser Distributor For ENDO Brands Products Kicks off sales week
  • Mar 01, 2019: Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting
  • Feb 28, 2019: Endo reports fourth-quarter and full year 2018 financial results
  • Jan 15, 2019: BGS-649 Phase 2b data to be Presented at ENDO 2019
  • Nov 28, 2018: Amsel Medical Corporation Announces Clearance of a 510(k) Pre-Marketing Notification by the US Food and Drug Administration for the Amsel Endo Occluder Device
  • Nov 09, 2018: Endo Pharmaceuticals Issues Voluntary Recall of Robaxin Tablets Bottle Packs due to Labeling Error
  • Nov 08, 2018: Endo reports third-quarter 2018 financial results
  • Oct 11, 2018: Endo presents data on the perception and measurement of cellulite severity at the American Society for Dermatologic Surgery (ASDS) Annual Meeting
  • Sep 28, 2018: Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • Endo International Plc, Key Facts
  • Endo International Plc, Key Employees
  • Endo International Plc, Key Employee Biographies
  • Endo International Plc, Major Products and Services
  • Endo International Plc, History
  • Endo International Plc, Other Locations
  • Endo International Plc, Subsidiaries
  • Endo International Plc, Key Competitors
  • Endo International Plc, Ratios based on current share price
  • Endo International Plc, Annual Ratios
  • Endo International Plc, Interim Ratios
  • Endo International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Endo International Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Endo International Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Endo International Plc, Performance Chart (2014 - 2018)
  • Endo International Plc, Ratio Charts
  • Endo International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Endo International Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Shire Plc
  • Purdue Pharma LP
  • MallInckrodt Plc
  • Jazz Pharmaceuticals Plc
  • Horizon Pharma Plc
  • Allergan Plc
  • Abbott Laboratories
Note: Product cover images may vary from those shown
Adroll
adroll